129 related articles for article (PubMed ID: 32071673)
1. BRM Targeting Compounds for the Potential Treatment of Cancer.
Kargbo RB
ACS Med Chem Lett; 2020 Feb; 11(2):99-100. PubMed ID: 32071673
[No Abstract] [Full Text] [Related]
2. Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy.
Gramling S; Rogers C; Liu G; Reisman D
Oncogene; 2011 Jul; 30(29):3289-94. PubMed ID: 21478905
[TBL] [Abstract][Full Text] [Related]
3. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
[TBL] [Abstract][Full Text] [Related]
4. The chromatin remodeling protein BRM regulates the transcription of tight junction proteins: Implication in breast cancer metastasis.
Yang Y; Liu L; Fang M; Bai H; Xu Y
Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):547-556. PubMed ID: 30946989
[TBL] [Abstract][Full Text] [Related]
5. PROTACs Targeting BRM (SMARCA2) Afford Selective
Berlin M; Cantley J; Bookbinder M; Bortolon E; Broccatelli F; Cadelina G; Chan EW; Chen H; Chen X; Cheng Y; Cheung TK; Davenport K; DiNicola D; Gordon D; Hamman BD; Harbin A; Haskell R; He M; Hole AJ; Januario T; Kerry PS; Koenig SG; Li L; Merchant M; Pérez-Dorado I; Pizzano J; Quinn C; Rose CM; Rousseau E; Soto L; Staben LR; Sun H; Tian Q; Wang J; Wang W; Ye CS; Ye X; Zhang P; Zhou Y; Yauch R; Dragovich PS
J Med Chem; 2024 Jan; 67(2):1262-1313. PubMed ID: 38180485
[TBL] [Abstract][Full Text] [Related]
6. Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers.
Rago F; DiMare MT; Elliott G; Ruddy DA; Sovath S; Kerr G; Bhang HC; Jagani Z
Biochem Biophys Res Commun; 2019 Jan; 508(1):109-116. PubMed ID: 30527810
[TBL] [Abstract][Full Text] [Related]
7. Targeting of BRM Sensitizes
Zernickel E; Sak A; Riaz A; Klein D; Groneberg M; Stuschke M
Mol Cancer Ther; 2019 Mar; 18(3):656-666. PubMed ID: 30478150
[TBL] [Abstract][Full Text] [Related]
8. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E
Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744
[TBL] [Abstract][Full Text] [Related]
9. Treatment Patterns and Outcomes of Women with Symptomatic and Asymptomatic Breast Cancer Brain Metastases: A Single-Center Retrospective Study.
Gao YK; Kuksis M; Id Said B; Chehade R; Kiss A; Tran W; Sickandar F; Sahgal A; Warner E; Soliman H; Jerzak KJ
Oncologist; 2021 Nov; 26(11):e1951-e1961. PubMed ID: 34506676
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada.
Wang XY; Rosen MN; Chehade R; Sahgal A; Das S; Warner E; Saskin R; Zhang B; Soliman H; Chan KKW; Jerzak KJ
JAMA Netw Open; 2022 Aug; 5(8):e2225424. PubMed ID: 35960523
[TBL] [Abstract][Full Text] [Related]
11. Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer.
Moraes FY; Mansouri A; Dasgupta A; Ramotar M; Kosyak N; Weiss J; Laperriere N; Millar BA; Berlin A; Conrad T; van Prooijen M; Heaton R; Coolens C; Winter J; Bernstein M; Zadeh G; Kongkham P; Doherty M; Shultz DB
Lung Cancer; 2021 May; 155():34-39. PubMed ID: 33721614
[TBL] [Abstract][Full Text] [Related]
12. Androgen Receptor Is Expressed in the Majority of Breast Cancer Brain Metastases and Is Subtype-Dependent.
Fan KY; Chehade R; Qazi M; Moravan V; Nofech-Mozes S; Jerzak KJ
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345085
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of brain metastases from solid tumours.
Cappuzzo F; Mazzoni F; Maestri A; Di Stefano A; Calandri C; Crino L
Forum (Genova); 2000; 10(2):137-48. PubMed ID: 10875975
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 expression in breast cancer brain metastases.
Chehade R; Qazi MA; Ennis M; Sahgal A; Das S; Nofech-Mozes S; Jerzak KJ
Neurooncol Adv; 2022; 4(1):vdac154. PubMed ID: 36299795
[TBL] [Abstract][Full Text] [Related]
15. Concerted genomic targeting of H3K27 demethylase REF6 and chromatin-remodeling ATPase BRM in Arabidopsis.
Li C; Gu L; Gao L; Chen C; Wei CQ; Qiu Q; Chien CW; Wang S; Jiang L; Ai LF; Chen CY; Yang S; Nguyen V; Qi Y; Snyder MP; Burlingame AL; Kohalmi SE; Huang S; Cao X; Wang ZY; Wu K; Chen X; Cui Y
Nat Genet; 2016 Jun; 48(6):687-93. PubMed ID: 27111034
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
Varešlija D; Priedigkeit N; Fagan A; Purcell S; Cosgrove N; O'Halloran PJ; Ward E; Cocchiglia S; Hartmaier R; Castro CA; Zhu L; Tseng GC; Lucas PC; Puhalla SL; Brufsky AM; Hamilton RL; Mathew A; Leone JP; Basudan A; Hudson L; Dwyer R; Das S; O'Connor DP; Buckley PG; Farrell M; Hill ADK; Oesterreich S; Lee AV; Young LS
J Natl Cancer Inst; 2019 Apr; 111(4):388-398. PubMed ID: 29961873
[TBL] [Abstract][Full Text] [Related]
17. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.
Willis MS; Holley DW; Wang Z; Chen X; Quintana M; Jensen BC; Tannu M; Parker J; Jeyaraj D; Jain MK; Wolfram JA; Lee HG; Bultman SJ
J Mol Cell Cardiol; 2017 Apr; 105():99-109. PubMed ID: 28232072
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.
Routh ED; Van Swearingen AED; Sambade MJ; Vensko S; McClure MB; Woodcock MG; Chai S; Cuaboy LA; Wheless A; Garrett A; Carey LA; Hoyle AP; Parker JS; Vincent BG; Anders CK
Front Oncol; 2022; 12():818693. PubMed ID: 35992833
[TBL] [Abstract][Full Text] [Related]
19. Identifying targets for the restoration and reactivation of BRM.
Kahali B; Gramling SJ; Marquez SB; Thompson K; Lu L; Reisman D
Oncogene; 2014 Jan; 33(5):653-64. PubMed ID: 23524580
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.
Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H
Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
